This content is in French.
Antimicrobial dose adaptation in obese subjects
1 avril 2024
Obesity is associated with pharmacokinetic and pharmacodynamic alterations, which can modify antimicrobial exposure when prescribed at usual doses. Prescribing the wrong dose in an obese subject can result in either…
Sign in to read the rest
Reserved for healthcare professionals, free registration.
Scientific reference
Ana Castro-Balado et al. Updated antimicrobial dosing recommendations for obese patients. Antimicrob Agents Chemother. 2024 Mar 25:e0171923
View the source
